Repertoire® Immune Medicines and Bristol Myers Squibb Announce Multi-Year Strategic Collaboration to Develop Tolerizing Vaccines for Autoimmune Diseases ...Middle East

Collaboration combines Repertoire's industry leading DECODE™ platform that uniquely maps the immune synapse to develop T cell targeted immune medicines with Bristol Myers Squibb's world-leading expertise in developing and commercializing innovative immune medicines Repertoire will receive...

Hence then, the article about repertoire immune medicines and bristol myers squibb announce multi year strategic collaboration to develop tolerizing vaccines for autoimmune diseases was published today ( Monday 29/04/2024 - 01:05 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Repertoire® Immune Medicines and Bristol Myers Squibb Announce Multi-Year Strategic Collaboration to Develop Tolerizing Vaccines for Autoimmune Diseases )

Also on site :

• Společnost TCL získala na CES 2026 několik ocenění za průlomové inovace v kategoriích televizorů, mobilních zařízení a chytrých domácností
• Best Accounting Software for Tax (2026): QuickBooks Named Trusted Tax-Ready Platform for Businesses by Expert Consumers
• CES 2026: Die Zukunft ist hier